Open AccessAbstract A119: Nanocarriers with a camptothecin-mitocan co-drug suppress tumor growth and extend survival in models of chemosensitive and chemoresistant neuroblastoma
Author(s) -
David T. Guerrero,
Ivan S. Alferiev,
Ferro Nguyen,
Peng Guan,
Venkatadri Kolla,
Danielle Soberman,
Ilia Fishbein,
Robert J. Levy,
Garrett M. Brodeur,
Michael Chorny
Publication year - 2018
Publication title -
molecular cancer therapeutics
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-8514
pISSN - 1535-7163
DOI - 10.1158/1535-7163.targ-17-a119
Subject(s) - nanocarriers , prodrug , camptothecin , pharmacology , drug , neuroblastoma , drug delivery , chemistry , combination therapy , in vivo , in vitro , cancer research , medicine , cell culture , biology , biochemistry , organic chemistry , genetics , microbiology and biotechnology